OmniAb (OABI) Amortization of Deferred Charges (2025 - 2026)
OmniAb's (OABI) quarterly Amortization of Deferred Charges came in at $580000.0 in Q1 2026, up 5.65% year-on-year from $549000.0 in Q1 2025, and up 5.65% on a QoQ basis from $549000.0 in Q1 2025.
OmniAb (OABI) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends
OmniAb (OABI) has 2 years of Amortization of Deferred Charges data on file, last reported at $580000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - |
| 3 | Akari Therapeutics | 1,021.31 Bn | 1,021.31 Bn | - |
| 4 | BeOne Medicines | 467.89 Bn | 463.10 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.19 Bn | 61.44 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.46 Bn | 63.46 Bn | - |
| 8 | Argenx Se | 55.64 Bn | 50.45 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | OmniAb | 267.30 Mn | 218.23 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 580,000.00 |
| Mar 31, 2026 | 580,000.00 |
| Mar 31, 2025 | 549,000.00 |
| Mar 31, 2025 | 549,000.00 |